Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenxiang Yangwei Capsule for Peptic Ulcer (Qi Deficiency and Qi Stagnation Pattern)
CTR20132451Phase 2Completed
- Sponsor
- Guangdong Zhongda Nanhai Marine Biotechnology Engineering
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shenxiang Yangwei in Peptic ulcer disease (PUD), gastric ulcer, duodenal ulcer, sponsored by Guangdong Zhongda Nanhai Marine Biotechnology Engineering. Started Feb 2014; status: completed.
02
Drugs
Shenxiang Yangwei
03
Conditions
Peptic ulcer disease (PUD)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20132451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132451.